Moderna begins Phase 3 trials of its COVID-19 vaccine candidate
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.